Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan B Bell

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Practical Radiation Oncology|February 1, 2023
Practical Considerations During Brachytherapy Applicator Placement for Locally Advanced Cervical CancerJonathan B Bell, Lorraine Portelance, Alberto de la Zerda, et al.
Scientific Reports|January 21, 2018
HDL nanoparticles targeting sonic hedgehog subtype medulloblastomaJonathan B Bell, Jonathan S Rink, Frank Eckerdt, et al.
Scientific Reports|September 8, 2019
Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastomaFrank Eckerdt, Jessica Clymer, Jonathan B Bell, et al.
Journal of Neuro-Oncology|May 27, 2017
Stereotactic radiosurgery for brain metastases from primary head and neck carcinomas: a retrospective analysisRajal A Patel, Jonathan B Bell, Thomas Kim, et al.
Scientific Reports|December 15, 2020
Combined PI3Kα-mTOR Targeting of Glioma Stem CellsFrank D Eckerdt, Jonathan B Bell, Christopher Gonzalez, et al.
Frontiers in Oncology|February 2, 2026
Association of thyroid disease and intracranial meningiomas: a retrospective analysis with external validationJonathan B Bell, Max A Saint-Germain, Carlen A Yuen, et al.
Radiation Oncology (London, England)|May 22, 2025
Defining occult disease in glioblastoma using spectroscopic MRI: implications for clinical target volume delineationJonathan B Bell, Sulaiman Sheriff, Mohammed Z Goryawala, et al.
Molecular Cancer Research : MCR|March 8, 2019
Potent Antineoplastic Effects of Combined PI3Kα-MNK Inhibition in MedulloblastomaFrank Eckerdt, Jonathan B Bell, Elspeth M Beauchamp, et al.
Radiation Oncology (London, England)|February 23, 2023
Delineation of recurrent glioblastoma by whole brain spectroscopic magnetic resonance imagingJonathan B Bell, William Jin, Mohammed Z Goryawala, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2024
Dynamics of Daily Glioblastoma Evolution During Chemoradiation Therapy on the 0.35T Magnetic Resonance Imaging-Linear AcceleratorKaylie Cullison, Kayla Samimi, Jonathan B Bell, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Practical Radiation Oncology|February 1, 2023
Practical Considerations During Brachytherapy Applicator Placement for Locally Advanced Cervical CancerJonathan B Bell, Lorraine Portelance, Alberto de la Zerda, et al.
Scientific Reports|January 21, 2018
HDL nanoparticles targeting sonic hedgehog subtype medulloblastomaJonathan B Bell, Jonathan S Rink, Frank Eckerdt, et al.
Scientific Reports|September 8, 2019
Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastomaFrank Eckerdt, Jessica Clymer, Jonathan B Bell, et al.
Journal of Neuro-Oncology|May 27, 2017
Stereotactic radiosurgery for brain metastases from primary head and neck carcinomas: a retrospective analysisRajal A Patel, Jonathan B Bell, Thomas Kim, et al.
Scientific Reports|December 15, 2020
Combined PI3Kα-mTOR Targeting of Glioma Stem CellsFrank D Eckerdt, Jonathan B Bell, Christopher Gonzalez, et al.
Frontiers in Oncology|February 2, 2026
Association of thyroid disease and intracranial meningiomas: a retrospective analysis with external validationJonathan B Bell, Max A Saint-Germain, Carlen A Yuen, et al.
Radiation Oncology (London, England)|May 22, 2025
Defining occult disease in glioblastoma using spectroscopic MRI: implications for clinical target volume delineationJonathan B Bell, Sulaiman Sheriff, Mohammed Z Goryawala, et al.
Molecular Cancer Research : MCR|March 8, 2019
Potent Antineoplastic Effects of Combined PI3Kα-MNK Inhibition in MedulloblastomaFrank Eckerdt, Jonathan B Bell, Elspeth M Beauchamp, et al.
Radiation Oncology (London, England)|February 23, 2023
Delineation of recurrent glioblastoma by whole brain spectroscopic magnetic resonance imagingJonathan B Bell, William Jin, Mohammed Z Goryawala, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2024
Dynamics of Daily Glioblastoma Evolution During Chemoradiation Therapy on the 0.35T Magnetic Resonance Imaging-Linear AcceleratorKaylie Cullison, Kayla Samimi, Jonathan B Bell, et al.
Pageof 2